⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 4 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 4 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT April 23, 2026

Pramipexol ratiopharm 0,52 mg Retardtabletten 0,52 mg (Retardtablette)

📷 Wikipedia: Pramipexole · Source
Pramipexol ratiopharm 0,52 mg Retardtabletten 0,52 mg (Retardtablette)
📷 Wikipedia: Pramipexole · Source
Pramipexole ratiopharm 0.52 mg prolonged-release tablets are delayed in supply.
✅
Resolved by agency
The issuing agency has confirmed this medicine alert is over — the underlying issue was addressed. Originally reported 34 days ago.
📈 Timeline
1 days in total
May 18, 2026 May 19, 2026

What is this? Pramipexol is a medicine used to treat Parkinson’s disease or restless legs syndrome. It comes in slow-release tablets.

What's happening? Some packs of this medicine are delayed and not available right now. Only the 30-tablet box is still in stock.

Does this affect me? If you take this medicine, check if your usual pack is missing. The shortage is in Austria.

What should I do? Ask your pharmacist or doctor for help finding a replacement or adjusting your supply.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Agency-published detail

ATC: N04BC05 · Reason: Verzögerung bei der Auslieferung · Marketing authorisation holder: Teva B.V., Swensweg 5, 2031 GA Haarlem, Niederlande · Affected packs: 10 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-04-20] · 30 Stück Schachtel, Blisterpackung [verfügbar]

First published
April 23, 2026
Last refreshed by us
1 week ago
Severity (as classified)
Low
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

High AT 1 month ago

Pramipexol Actavis 0,18 mg Tabletten 0,18 mg (Tablette)

Pramipexole Actavis 0.18 mg tablets are currently unavailable due to a manufacturing delay. Parallel export is prohibited.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Pramipexol ratiopharm 0,52 mg Retardtabletten 0,52 mg (Retardtablette). Pramipexole ratiopharm 0.52 mg prolonged-release tablets are delayed in supply.
▸ When was this alert issued?
This alert was issued on April 23, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Low risk. A low risk means harm is unlikely under normal use. The alert is informational but still worth reading.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.